SAITO Tsuyoshi

Researcher's full information

Articles

• Enhancing endogenous adenosine A2A receptor signaling induces slow-wave sleep without affecting body temperature and cardiovascular function
  Korkutata Mustafa; Saitoh Tsuyoshi; Cherasse Yoan; Iok...
  Neuropharmacology/144/pp.122-132, 2018-10
  
  CiNii PubMed Tsukuba Repository
• SYNTHESIS OF NOVEL 1,3-DIOXA-5-THIAZATRIQUINANE AND 1-OXA-3,5-DITHIAZATRIQUINANE DERIVATIVES AND THEIR PHARMACOLOGIES
  Ohshita Ryuichiro; Kutsumura Noriki; Nagumo Yasuyuki; Yam...
  HETEROCYCLES/97(2)/pp.687-695, 2018-09
• Large-scale forward genetics screening identifies Trpa1 as a chemosensor for predator odor-evoked innate fear behaviors
  Wang Yibing; Cao Liqin; Lee Chia-Ying; Matsuo Tomohik...
  Nature communications/9(1)/p.2041, 2018-05
  
  PubMed Tsukuba Repository
• Orexin agonist improves inflammation-induced immobility
  Uchida Shuntaro; Sakurai Takeshi; Irukayama Yoko T; Og...
  Proceedings for Annual Meeting of The Japanese Pharmacological Society/2018/pp.OR23-1, 2018
  
  CiNii
• Controlled decoration of boron-doped diamond electrodes by electrochemical click reaction (e-CLICK)
  Yamamoto Takashi; Akahori Miku; Natsui Keisuke; Saitoh T...
  CARBON/130/pp.350-354, 2018-04
• Toward bioluminescence in the near-infrared region: Tuning the emission wavelength of firefly luciferin analogues by allyl substitution
  Kitada Nobuo; Saitoh Tsuyoshi; Ikeda Yuma; Iwano Satoshi...
  TETRAHEDRON LETTERS/59(12)/pp.1087-1090, 2018-03
• A solvent-directed stereoselective and electrocatalytic synthesis of diisoeugenol
  Yamamoto Takashi; Riehl Barbara; Naba Keisuke; Nakahara ...
  Chemical communications (Cambridge, England)/54(22)/pp.2771-2773, 2018-03
  
  PubMed
• Favorskii-Type Rearrangement of the 4,5-Epoxymorphinan Skeleton
  Kutsumura Noriki; Koyama Yasuaki; Suzuki Yuko; Tominaga ...
  Organic letters/20(6)/pp.1559-1562, 2018-03
  
  PubMed
• Nonpeptide Orexin-2 Receptor Agonist Attenuates Morphine-induced Sedative Effects in Rats
  Toyama Satoshi; Shimoyama Naohito; Tagaito Yugo; Nagase ...
  Anesthesiology/128(5)/pp.992-1003, 2018-03
  
  PubMed
• オレキシン研究の進展と新規受容体作動薬の創製
  斉藤 毅; 長瀬 博
  バイオサイエンスとインダストリー(B&I)/76(2)/pp.127-129, 2018-02
• ダイヤモンド電極を活用した有機電解反応の進展
  山本 崇史; 斉藤 毅; 栄長 泰明
  <i>NEW DIAMOND<i/>/34(2)/pp.26-29, 2018-02
• An Allylated Firefly Luciferin Analogue with Luciferase Specific Response in Living Cells
  Ikeda Yuma; Saitoh Tsuyoshi; Niwa Kazuki; Nakajima Takah...
  <i>Chemical Communications</i>/54(14)/pp.1774-1777, 2018-02
  
  PubMed
• ALLOSTERIC MODULATION OF ADENOSINE A(2A) RECEPTORS IN MICE INDUCES SLOW-WAVE SLEEP WITHOUT CARDIOVASCULAR EFFECTS
  Korkutata M.; Saitoh T.; Feng D.; Murakoshi N.; Sugiy...
  SLEEP MEDICINE/40(1)/pp.E181-E181, 2017-12
• Essential structure of orexin 1 receptor antagonist YNT-707, Part II: Drastic effect of the 14-hydroxy group on the orexin 1 receptor antagonistic activity
  Ohrui Sayaka; Yamamoto Naoshi; Saitoh Tsuyoshi; Kutsumura...
  Bioorganic & Medicinal Chemistry Letters/28(4)/pp.774-777, 2017-12
  
  PubMed
• The application of a specific morphinan template to the synthesis of galanthamine
  Yamamoto Naoshi; Okada Takahiro; Harada Yukimasa; Kutsumu...
  TETRAHEDRON/73(39)/pp.5751-5758, 2017-09
• The application of a specific morphinan template to the synthesis of galanthamine
  Yamamoto Naoshi; Okada Takahiro; Harada Yukimasa; Kutsumu...
  TETRAHEDRON/73(39)/pp.5751-5758, 2017-09
• Essential structure of orexin 1 receptor antagonist YNT-707, Part I: Role of the 4,5-epoxy ring for binding with orexin 1 receptor
  Yamamoto Naoshi; Ohrui Sayaka; Okada Takahiro; Yata Masa...
  Bioorganic & medicinal chemistry letters/27(17)/pp.4176-4179, 2017-09
  
  PubMed
• Synthesis of heterocyclic compounds with adamantane-like cage structures consisting of phosphorus, sulfur, and carbon
  Kutsumura Noriki; Ohshita Ryuichiro; Horiuchi Jumpei; Tat...
  TETRAHEDRON/73(34)/pp.5214-5219, 2017-08
  
  Tsukuba Repository
• Antitrichomonal activity of δ opioid receptor antagonists, 7-benzylidenenaltrexone derivatives
  Kutsumura Noriki; Koyama Yasuaki; Nagumo Yasuyuki; Nakaji...
  Bioorganic & medicinal chemistry/25(16)/pp.4375-4383, 2017-08
  
  PubMed
• IIIS 発 ナルコレプシー治療薬開発に向けた取り組み
  ⻫藤 毅; 入鹿山 容子; 柳沢 正史; ⻑瀬 博
  なるこ/(34)/pp.8-10, 2017-05
• Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models.
  Y Irukayama-Tomobe; Y Ogawa; H Tominaga; Y Ishikawa; N H...
  Proc Natl Acad Sci U S A., 2017-05
  
  PubMed
• Click Reaction Based on the Biosynthesis of Firefly Luciferin
  Toyama Tomohisa; Saitoh Tsuyoshi; Takahashi Yuka; Oka Ko...
  Chemistry Letters/46(5)/pp.753-755, 2017-05
  
  CiNii
• A small molecule orexin receptor agonist promotes recovery from inflammation-induced immobility
  Uchida Shuntaro; Irukayama Yoko; Ogawa Yasuhiro; Tominaga...
  JOURNAL OF PHARMACOLOGICAL SCIENCES/133(3)/p.S163, 2017-03
• Histological and electrophysiological analysis of a small-molecule OX2R-slective agonist YNT-185
  Ogawa Yasuhiro; Irukayama Yoko; Tominaga Hiromu; Hosokawa...
  JOURNAL OF PHARMACOLOGICAL SCIENCES/133(3)/p.S163, 2017-03
• Design and Synthesis of Potent and Highly Selective Orexin 1 Receptor Antagonists with a Morphinan Skeleton and Their Pharmacologies
  Nagase Hiroshi; Yamamoto Naoshi; Yata Masahiro; Ohrui Sa...
  JOURNAL OF MEDICINAL CHEMISTRY/60(3)/pp.1018-1040, 2017-02
  
  PubMed
• more...